Dyadic Logo Current.jpg
Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
January 02, 2024 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
December 20, 2023 07:00 ET | Rentschler Biopharma SE
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
December 07, 2023 04:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
Image of Liberation Labs biomanufacturing facility under construction
USDA Awards $25 Million Loan Guarantee to Ameris Bank for Liberation Labs Biomanufacturing Facility in Indiana
November 30, 2023 08:00 ET | Liberation Labs
USDA Awards $25 Million Loan Guarantee to Ameris Bank for Liberation Labs' Biomanufacturing Facility in Indiana
22157.jpg
Cell Expansion Market Size, Share & Trends Analysis Report 2023-2030, Featuring Profiles of Thermo Fisher Scientific, GE Healthcare, Corning, Merck, Sartorius and More
November 15, 2023 09:33 ET | Research and Markets
Dublin, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The "Cell Expansion Market Size, Share & Trends Analysis Report By Product (Instruments, Culture Flasks & Accessories, Consumables), By Cell Type...
Dyadic Logo Current.jpg
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 08, 2023 16:00 ET | Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
22157.jpg
Global Digital Biomanufacturing Market Analysis Report 2023-2027 - Partnerships Driving Adoption of Modern Manufacturing Technologies
October 16, 2023 06:58 ET | Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology, By Application, By...
22157.jpg
China's Position in the Global Biopharmaceutical Manufacturing Industry: 2023 Insights - Navigating the Evolving Landscape
October 13, 2023 04:03 ET | Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "China's Position in Global Manufacturing: A Comparison of China's Emerging Position vs Established Regions' Manufacturing Capacity and Production"...
CBC Logo.png
California Biomanufacturing Center Awarded ARPA Grant to Train Biotechnology Workforce
October 10, 2023 11:15 ET | California Biomanufacturing Center
The California Biomanufacturing Center said the City of Vacaville awarded it a two-year, $750,000 grant to retrain displaced workers.
Dyadic Logo Current.jpg
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...